(Q50802107)
Statements
Prostate cancer screening strategies with re-screening interval determined by individual baseline prostate-specific antigen values are cost-effective. (English)
1 reference
Kobayashi T
1 reference
Goto R
1 reference
Ito K
1 reference
Mitsumori K
1 reference
3 April 2007
1 reference
33
1 reference
6
1 reference
783-789
1 reference